Patent & IP news for August 5, 2011

Patent Litigations



Patent & IP Blogs

post image Friday fantasies from

Friday has come round again and, with it, a priceless moment to contemplate the array of future attractions -- so check out the IPKat's Forthcoming Events page here and see what takes your fancy!

"IPTV ...

Share via E–mail | Twitter | Facebook

post image July employment from

Surprise! What a difference (maybe) a day makes. Yesterday, the economic news was all gloom and doom. Today, the outlook looks a little brighter. The employment news from BLS this morning showed a gain of ...

Share via E–mail | Twitter | Facebook

post image Rear Wheels from

Albert Fairclough got 5,622,375 for a two-child push-chair. During earlier prosecution of the family, Fairclough found out about a couple of highly material prior art references, which he duly neglected to inform the ...

Share via E–mail | Twitter | Facebook

post image The Impact of Patent Reform on Filing Strategy (I) from

The new law defining prior art would become effective 18–months from the date of enactment of H.R. 1249. Patent applications filed after that date would be bound by the new first-to-file rules. The ...

Share via E–mail | Twitter | Facebook

post image A Small Step for Natco, a Giant Leap for Generic Drugs: India’s first Compulsory Licensing Application Filed from

In a landmark move, Natco Pharma has filed India’s first compulsory licensing application against Bayer’s patented drug Nexavar, which is used to treat liver and kidney cancer. The full ET Report which covers ...

Share via E–mail | Twitter | Facebook

post image Bratz Trade Secret Litigation $309 million from

 Bratz Dolls  As an update to the Bratz litigation, the Court has ordered Mattel, Inc. to pay MGA Entertainment $309 million.  In one of our prior posts which can be read here, Mattel initially sued ...

Share via E–mail | Twitter | Facebook

Biotech/Pharma Docket from

By James DeGiulio -- Medicis and Lupin Settle Solodyn Infringement Dispute; Agree to Drug Development Collaboration Medicis has entered into multiple agreements with Lupin over the acne drug Solodyn, allowing the generic drugmaker to enter the ...

Share via E–mail | Twitter | Facebook

AMP v. USPTO: Standing from

By Kevin E. Noonan -- One of the many questions in the Association for Molecular Pathology v. U.S. Patent and Trademark Office (Myriad) case decided by the panel was whether the plaintiffs had standing to ...

Share via E–mail | Twitter | Facebook

The IPKat challenge; when was a company formed? from

IPKat, noted "the celebrations of IBM occasioned reflections on the handful of companies that have succesfully remade themselves multiple times. How many such prominent companies are there and how far back do they reach in ...

Share via E–mail | Twitter | Facebook

Sparring between Google and Microsoft as to Novell patent saga from

Nick Wingfield at blogs.wsj has some details on "how to interpret" communications between Google and Microsoft relating to the sale of patents once owned by Novell.

keywords: false ‘gotcha!', Google lawyer Kent Walker, Microsoft ...

Share via E–mail | Twitter | Facebook

Treasuries still safe haven from

One of the "good" pieces of news from yesterday's market debacle is that Treasury bill and bonds are still seen as a safe haven - even after the debt ceiling debate. Investors rushed into the ...

Share via E–mail | Twitter | Facebook

RPX Issues Second Quarter Results And Comments On The ‘Patent Bubble’ from

Patent aggregator RPX's second quarter results showed $38.8 MM in revenue and total equity increasing to $250 MM. According to its earnings forecast, RPX expects to see about $150 MM in total revenue ...

Share via E–mail | Twitter | Facebook

Patent Reform: Quantity and Quality from

Aaron Thalwitzer I’ve written previously about the U.S. Supreme Court case Microsoft v. i4i, which upheld the “clear and convincing” standard required to invalidate a patent. As we know, this is unusual. Civil ...

Share via E–mail | Twitter | Facebook

Top 5: TED Talks about Crowdsourcing and Innovation from

TED, or Technology Entertainment and Design, is a "non-profit devoted to Ideas Worth Spreading."  TED is known for their conferences featuring some of the world's most innovative speakers.  Many of the presentations driven by ...

Share via E–mail | Twitter | Facebook

The UK's Technology Strategy Board from

In 2007 the UK government created the Technology Strategy Board. its remit is to be the national innovation agency and to "accelerate economic growth by stimulating and supporting business-led...

(From Steve van Dulken's Patents ...

Share via E–mail | Twitter | Facebook

Oracle v. Google: NDCA Judge Alsup Rejects Nash Bargaining Solution and Grants Google’s Motion to Exclude Oracle’s Expert’s Report and Testimony Advocating $1.4B to $6.1B in Damages from

The battle between Oracle and Google, concerning patent and copyright infringement relating to features of Java and Android, is approaching an October trial date. Damages is a huge issue in the case—in fact, in ...

Share via E–mail | Twitter | Facebook

Twombly and Iqbal, Not Form 18, Dictate Pleading Standard for Indirect Infringement from

In ruling on defendant's motion to dismiss plaintiff's indirect infringement claims, the court found that Twombly and Iqbal, not Form 18, controlled. "Since [Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007 ...

Share via E–mail | Twitter | Facebook

Friday Foreign Filing Roundup from

Here's a recap of the foreign filing/patent law news from this week:

Share via E–mail | Twitter | Facebook

USPTO to Hold California Independent Inventors Conference from

If you are a serious inventor you need to go to this Conference. Last year there were inventors who came to the USPTO campus for the two-day event from all over the East Coast, and ...

Share via E–mail | Twitter | Facebook

ACI Maximizing Pharmaceutical Patent Lifecycles Conference from

American Conference Institute (ACI) will be holding its 12th Annual Maximizing Pharmaceutical Patent Lifecycles conference on October 4-5, 2011 in New York, NY. The conference will allow attendees to: • Understand how the patent cliff will ...

Share via E–mail | Twitter | Facebook

Facebook v. Shagbook from

By: Rene Dial   We have seen this time and time again as companies try to use some variation of the Facebook name to bolster their websites.  Facebook continues to defend the Facebook trademark from various ...

Share via E–mail | Twitter | Facebook

Guest Post: What We Said (and Didn’t Say) in the Berkeley Patent Study from

Guest Post by Robert Merges, Pam Samuelson, and Ted Sichelman In 2008, along with Stuart Graham (now Chief Economist at the USPTO) and Robert Barr (Executive Director of the Berkeley Center for Law &Technology;), we ...

Share via E–mail | Twitter | Facebook

Contempt Process: Fast-Forward from

The following is excerpted from an August 1, 2011 article on how the Federal Circuit has made it easier to enforce injunctions in patent cases by Steven Seidenberg published by the ABA Journal: The U ...

Share via E–mail | Twitter | Facebook

In dispute with Google, Oracle asks Chicago court to compel deposition of Motorola Mobility from

Oracle's lawsuit against Google has been going on for almost exactly a year before the U.S. District Court for the Northern District of California (San Francisco), and one particular element of the dispute ...

Share via E–mail | Twitter | Facebook

Association of Molecular Pathology v. USPTO from

The CAFC opinion in this case was issued on July 29, 2011.  This case has alternatively been known as ACLU v. Myriad or the Myriad gene patent case.  In a 2-1 decision, the Court of ...

Share via E–mail | Twitter | Facebook

Federal Circuit Affirms Validity of Argatroban Patent from

Mitsubishi Chemical Corp. v. Barr Labs., No. 2010-1432 (Fed. Cir. 2011) Mitsubishi Chemical owns U.S. Patent No. 5,214,052, which claims a "method for dissolving an arginineamide, comprising dissolving [argatroban] and/or its ...

Share via E–mail | Twitter | Facebook

Recess Appointments? from

One might wonder if the Senate Judiciary Committee is daring the Obama Administration to make some judicial recess appointments (or complicit in him doing so).  On its website, the Senate Judiciary Committee currently has this ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2014 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact